Quality-of-life study for people with cystinosis
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This is an observational study that asks people with nephropathic cystinosis about their quality of life while taking cystine-depleting treatment (cysteamine). It may help researchers better understand how this condition and treatment affect daily living.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of nephropathic cystinosis
- You are currently taking cysteamine by mouth as cystine-depletion therapy
- You are able and willing to sign the informed consent form
- You will follow the study visit/questionnaire plan as instructed by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cysteamine affects the bone health of people with nephropathic cystinosis, a rare genetic condition. It includes children and adults who are already taking cysteamine by mouth and will follow the study plan closely.
This trial tests a new gene therapy called DFT383 for children aged 2 to 5 with nephropathic cystinosis. It aims to see if the treatment is safe and can help improve kidney function.
This trial gathers information about adults with cystic fibrosis at the Erasme Hospital in Belgium. Your participation helps doctors better understand the condition and how it affects quality of life.
This study is testing a health-and-quality-of-life questionnaire for children and young adults with cystinosis. If you join, you may complete surveys and take part in interviews to help make the questions clearer and more useful.
This trial looks at the use of cysteamine to treat cystinosis, a rare inherited condition. It may help lower harmful cystine buildup in the body and improve outcomes, especially early in life.
This study gathers information from people with cystinosis to learn more about the condition. You may be able to join if you have a confirmed diagnosis.
Hear when a new Nephropathic Cystinosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.